130 related articles for article (PubMed ID: 10545015)
1. Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.
Dokianakis DN; Varras MN; Papaefthimiou M; Apostolopoulou J; Simiakaki H; Diakomanolis E; Spandidos DA
Clin Exp Metastasis; 1999 Jun; 17(4):293-7. PubMed ID: 10545015
[TBL] [Abstract][Full Text] [Related]
2. Detection and clinical correlations of ras gene mutations in human ovarian tumors.
Varras MN; Sourvinos G; Diakomanolis E; Koumantakis E; Flouris GA; Lekka-Katsouli J; Michalas S; Spandidos DA
Oncology; 1999; 56(2):89-96. PubMed ID: 9949292
[TBL] [Abstract][Full Text] [Related]
3. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
[TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination.
Yamashita K; Kuba T; Shinoda H; Takahashi E; Okayasu I
Am J Clin Pathol; 1998 Jun; 109(6):704-11. PubMed ID: 9620027
[TBL] [Abstract][Full Text] [Related]
6. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
7. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
[TBL] [Abstract][Full Text] [Related]
8. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
10. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
11. K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.
Høgdall EV; Høgdall CK; Blaakaer J; Christensen L; Bock JE; Vuust J; Glud E; Kjaer SK;
Gynecol Oncol; 2003 Apr; 89(1):31-6. PubMed ID: 12694651
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases.
Nomoto S; Nakao A; Ando N; Takeda S; Kasai Y; Inoue S; Kaneko T; Takagi H
Semin Surg Oncol; 1998; 15(1):40-6. PubMed ID: 9671955
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
14. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.
Cuatrecasas M; Erill N; Musulen E; Costa I; Matias-Guiu X; Prat J
Cancer; 1998 Mar; 82(6):1088-95. PubMed ID: 9506354
[TBL] [Abstract][Full Text] [Related]
16. [Mutational activation of H-ras and K-ras (Codon 12,61) genes in 7,12 dimethylbenz(a)anthracene induced rat ovarian tumors].
Kataoka A; Nishida T; Sugiyama T; Hirakawa N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):119-24. PubMed ID: 8429245
[TBL] [Abstract][Full Text] [Related]
17. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
[TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
[TBL] [Abstract][Full Text] [Related]
19. Activation of the ras genes in malignant and premalignant colorectal tumors.
Glarakis IS; Savva S; Spandidos DA
Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
